Blog post
Longenesis Partners with Dante Genomics to Offer Whole Genome Sequencing Solutions for Women’s Health in Europe
L’AQUILA, Italy, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Biotechnology startup Longenesis has partnered with Dante Genomics, a global leader in genomics...
Dante Genomics creates separate drug discovery and development company Genomic Biopharma Inc.
NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, today announced the...
Dante Genomics Unveils Digital Health Population Genomic Programs at the United Nations General Assembly Science Summit
NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, is pleased to...
Dante Genomics to innovate universal genomics by now offering easy, at-home blood collection kits for clinical whole genome sequencing without the use of a needle
NEW YORK, September 1, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, announced today...
Mainz Biomed and Dante Genomics Announce Full Commercial Availability of ColoAlert in Italy and the United Arab Emirates
BERKELEY, Calif. and MAINZ, Germany and NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz'' or...
Dante Genomics to Participate in a Panel Presentation at the Canaccord Genuity 42nd Annual Growth Conference
NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, today announced that members...
Dante Genomics partners with Emirates Post to deliver advanced genomic services in UAE
The partnership aims to enable universal access to genomic-driven wellness and longevity June 22, 2022 Emirates Post, the...
Dante Labs highlights advancements to its drug discovery development program, demonstrating the value of genomic data to drug discovery
NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, highlights significant progress made...
